FierceBiotech

Enbrel® (etanercept) Significantly Improved Scalp Involvement in Patients with Moderate to Severe Plaque Psoriasis

THOUSAND OAKS, Calif. and COLLEGEVILLE, Pa., Feb. 4, 2011 /PRNewswire/ -- Amgen (Nasdaq: AMGN) and Pfizer Inc. (NYSE: PFE) today announced results from a new trial that demonstrated Enbrel® ...
FiercePharma

Treatment With Enbrel® (etanercept) Shows Significant and Sustained Clinical Benefits in Rheumatoid Arthritis (RA) Patients With

ENBREL is indicated for reducing signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis (JIA) in children ages 2 years and older. ENBREL is indicated for ...
EurekAlert!

ENBREL is first therapy approved for psoriatic arthritis

SEATTLE, WA – Immunex Corporation (Nasdaq: IMNX) and Wyeth-Ayerst Laboratories, a division of American Home Products (NYSE: AHP) announced today that the U.S. Food and Drug Administration (FDA) has ...
EurekAlert!

Enbrel(R) is first therapy shown to inhibit bone and joint damage in PsA

THOUSAND OAKS, Calif., and RADNOR, Penn., – Results from a study of ENBREL® (etanercept), the only fully human TNF receptor, were presented demonstrating significant inhibition in the progression of ...
FierceBiotech

Enbrel® (etanercept) Patent Issued

THOUSAND OAKS, Calif., Nov. 22, 2011 /PRNewswire/ -- Amgen (NASDAQ:AMGN) today issued the following statement: Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel ® ...
Insurancenewsnet.com

Data Presented at Two Global Medical Congresses Reinforce Benefit of Enbrel® (etanercept) for Patients with Chronic Inflammatory Conditions

THOUSAND OAKS, Calif. and NEW YORK, May 25, 2011 /PRNewswire/ -- Amgen (NASDAQ: AMGN) and Pfizer Inc. (NYSE: PFE) today announced new results from multiple studies of ENBREL, further expanding the ...
Monthly Prescribing Reference

Updated labeling for Enbrel

Amgen and Wyeth have announced that the prescribing information for Enbrel (etanercept) has been updated. The previously bolded warning relating to the risk of infections and tuberculosis (TB) is now ...
MedCity News

Speaking the latest language of healthcare: Digital health tech

Whether starting or maintaining treatment, the Embark App has multiple features that can help patients on ENBREL throughout their treatment experience. As the healthcare industry continues to evolve ...
Business Wire

Enbrel - Drug Insight, 2019-2021 with Historical & Forecasted Sales Analysis - ResearchAndMarkets.com

DUBLIN--(BUSINESS WIRE)--The "Enbrel - Drug Insight, 2019" report has been added to ResearchAndMarkets.com's offering. Enbrel Drug Insight, 2019 highlights the drug marketed details and the Global API ...
Healthline

Enbrel Interactions: Alcohol, Medications, and Others

Enbrel (etanercept) is a prescription drug used to treat certain inflammatory conditions. This drug can interact with certain medications and vaccines. For example, Enbrel can interact with infliximab ...
Medscape

Black Box Warning Issued for Etanercept Regarding Infections

March 18, 2008 — A black box warning has been issued for etanercept (Enbrel, manufactured by Immunex Corporation; marketed by Amgen and Wyeth Pharmaceuticals) regarding the risk for tuberculosis and ...